Joanne Wendy Kim bought $5,450 of BIVI
Chief Financial Officer at BIOVIE INC.. 2,500 shares at an average of $2.18, traded Aug 28, 2026, filed Aug 28, 2026.
Score components
- +22RoleCFO
- 0Trade size$5k at market
- +10Relative to holdingsHoldings up 266%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001520138-26-000379, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | POpen-market purchase Common Stock | +2,500 | $2.18 | $5,450 | 3,441 | Aug 28, 2026 |
Related signals
Other insiders at BIOVIE INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | BIOVIE INC. | Cuong Do V President & CEO | $32k 15,210 shares | +1677% | |
| 38Weak | BIOVIE INC. | Amy Suzon Chappell director | $1,570 727 shares | - | |
| 40Moderate | BIOVIE INC. | Joseph M Palumbo Chief Medical Officer | $10k 4,843 shares | +406% | |
| 46Moderate | BIVIsell BIOVIE INC. | Steve Gorlin director | $128k 75,680 shares | -62% | |
| 46Moderate | BIVIbuy BIOVIE INC. | Cuong Do V President & CEO | $18k 10,000 shares | +17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.